a hub for research, education & best practice
A network serving as a valuable resource for healthcare professionals working in the field of ILD, promoting research, education, and best practice in the diagnosis and management of these lung disorders.
The ILD-IN provides a supportive network for all members, encourages information sharing and promotes best practice and research collaboration.
The ILD-IN provides resources and materials and encourages members to develop knowledge and expertise in ILD care.
Through peer support and education, the ILD-IN aims to raise the standard and provision of ILD care.
Our purpose is to provide a supportive network for health professionals of all disciplines working in interstitial lung diseases. ILD-INs purpose is, to provide support, promote ILD specialty practice through education and professional development and to influence the policy of ILD care.
The Interstitial Lung Disease Interdisciplinary Network (ILD-IN) is a supportive and collaborative network for health professionals of all disciplines caring for people with interstitial lung disease (ILD).
The ILD-IN is keen to support the development of regional networks supporting healthcare professionals specialising in ILD locally.
New and established regional groups and their contacts are listed along with details of the next planned meeting. We would be pleased to list your network.
Take a look at our social wall to stay up-to-date on the latest events and news in the industry.
We have a new information leaflet about Sarcoidosis Medication📣It covers different treatment options, how they work, their administration & potential side effects.
Thank you to Dr K Bechman and Dr J Galloway 💙
Download: https://buff.ly/4aDCalO
Order: https://buff.ly/4cR1ciO
Good exploratory work Eating & drinking experience in patients with IPF: qualitative study @BMJ_Open Fear of choking highlighted here - how often do we include #SALT assessment in our ILD clinics? @ImperialNHS @ild_inn @uhbtrust @gburgeILDNN @EuroRespSoc
European Respiratory Journal: 1-year DLCO decline was a better indicator of mortality than 1-year FVC decline in patients with >10% emphysema. In non-CPFE IPF patients, 1-year FVC declines >5% and >10% showed comparable mortality associations. https://bit.ly/48pyqDX
Session on Tai chi , use of a ‘breath ball’ to demonstrate how we breathe at different depths and a tool to reduce anxiety - session enjoyed by all including staff
And day two begins #GCOM2024... There is strength in collaboration and co operation @MIHRAfoundation @SaketkooMD @LatikaGupta_. 2024 fellows enthusiastic to contribute @antoniamariav & new members welcome @ild_inn
#ILD in #IIM Erin Wilfong @VanderbiltU speaks to why it matters. More Pulmonology/Rheumatology joint clinics & MDTs needed. Extra pulmonary disease impacts outcome in IIM-ILD @ild_inn @uhbtrust @Drchuntley089 @adamalih @unibirmingham
Predicting progressive disease and mortality in IPF using automated analysis of CT scans. A massive collaborative effort between @ImperialNHLI @qureight & @AstraZeneca now in press @ATSBlueEditor #cureipf
https://www.atsjournals.org/doi/abs/10.1164/rccm.202311-2185OC
Julie Hocking - congratulations on an outstanding career. You have been wonderful to work with and we hope we will continue to see you! Enjoy the part-time retirement!
Julie Chapman has been fabulous to work with over the years. Incredibly supportive and hardworking. Best of luck with the new chapter!